Participated · Equity · Jun 2018

Regroup provides remote, clinical‑level mental health care by supplying clinician capacity, workflows, and the technology to deliver telepsychiatry services. The company’s platform partners with clinicians to connect patients across its current 19‑state footprint; over 50% of partnered clinicians work exclusively for Regroup. Founded in 2011, Regroup has pursued outside funding to scale operations and product capabilities. The company recently raised $5.5 million to expand clinician capacity and improve efficiency through automation and product enhancements aimed at reducing clinician administrative burden. Regroup plans to strengthen its sales and account management teams and to develop targeted products addressing specific epidemics and substance‑use challenges. Its prior financing included a $6.1 million Series A raised last year from investors including Further Fund and Hyde Park Angels. Regroup Therapy provides virtual staffing of psychiatrists and other mental health professionals to hospitals, outpatient facilities, correctional facilities and Native American reservations. The company is led by CEO and Founder David Cohn. It delivers about 4,000 sessions per month through its existing network of providers. Regroup will use new funding to expand its network of psychiatrists, advanced psychiatric nurses, therapists and other mental health professionals. The company also plans to design and develop new functionality to improve its provider platform and to explore integrating additional data streams into its data platform. Regroup Therapy operates a telebehavioral-health platform that enables hospitals, health systems and primary care clinics to connect patients with remote psychiatrists, social workers and mental-health professionals via video visits. The company positions itself as a staffing solution for health entities, supplying clinicians along with technology, workflows and EMR-integrated documentation so remote providers function as part of local care teams. After launching in early 2015, Regroup has secured contracts with Sinai Health System, Oak Street Health, OSF HealthCare and MetroFamily Services. CEO David Cohn said the company expects no less than half a million dollars in revenue this year. Regroup is experimenting with facial-recognition signals as a proxy for outcomes and building out data analytics to identify population needs and track post-visit results. The team aims to reduce the national shortage of mental-health providers and to automate parts of the therapeutic process and patient self-management, particularly for value-based care systems.

Participated · Seed · Nov 2017

CFX Markets operates a proprietary secondary-market platform that securely facilitates trades in alternative assets such as REITs, limited partnerships, Regulation D, EB-5, Regulation A+, LLCs and BDCs. Led by managing directors Jordan Fishfeld and Juan Hernandez, the company uses custom-built software to match buyers and sellers and support trading workflows. Since launching in January 2016 the platform has completed thousands of transactions. The company plans to use new funding to expand into new markets and accelerate development of innovations in trading, clearing and settlement, and distributed ledger technology. CFX Markets maintains offices in Chicago, Los Angeles and New York City.

Participated · Series A · Aug 2017

ExplORer Surgical offers a platform that combines video, role-specific digital procedural playbooks, and time-stamped intraoperative data capture to support virtual proctoring, case support, clinical trials data collection, and product launches. The company originated from a research laboratory in the University of Chicago Medical Center Department of Surgery and integrates remote, HIPAA-compliant two-way video connectivity so offsite team members can join procedures. Its Remote Case Support feature, launched in early 2020, drove a 6X increase in sales over the last year. ExplORer has built more than 1,000 unique procedures on its platform and onboarded over 10 new medical device customers in under three months, including large global MedTech companies and startups. The company plans to use the new funding to grow headcount from about 30 to roughly 50, expand technology, marketing, and customer success teams, and deliver additional platform updates; it also expects to raise another round later this year. ExplORer Surgical offers a software-as-a-service platform for intraoperative surgical and interventional procedure workflow management and analytics. The platform lets hospital and device company teams guide, track and analyze activity in the operating room, during training events and throughout stages of clinical use. Each team member sees their own content on any connected device, and the system collects live procedural data. Led by CEO and co-founder Jennifer Fried, the company is based in Chicago, IL. ExplORer intends to use the recently raised funds to accelerate growth of its surgical software platform. The article does not disclose revenue or user metrics. ExplORer Surgical offers a software-as-a-service interactive digital playbook to manage, track and analyze intra-operative activity and information for operating rooms and interventional suites. The platform supports team coordination during procedures and delivers granular analytics on procedure activity. Customers include hospitals and medical device manufacturers that use the tool to improve intraoperative workflow and data capture. The company was founded out of a research laboratory at the University of Chicago Medical Center and is led by CEO Jennifer Fried. ExplORer intends to use the new financing to accelerate commercialization of its workflow management platform. The company is based in Chicago, Illinois. ExplORer Surgical builds an interactive surgical playbook as a software-as-a-service intraoperative workflow management tool. The platform aims to optimize operating room teamwork by preventing delays and disruptions caused by missing or incorrect instruments. It also seeks to reduce instances of opened-but-unused disposable items and to capture granular intraoperative data in real time. The company is led by CEO and co-founder Jennifer Fried, with Dr. Alex Langerman as Chief Medical Officer, Dr. Marko Rojnica, Eugene Fine as CTO, and Tom Knight as COO. ExplORer says it will use the funding to scale operations.

Participated · Seed · Sep 2016

Intelinair develops AGMRI®, a crop intelligence platform that aggregates and analyzes high-resolution aerial, satellite, and drone imagery plus equipment, weather, and scouting data. The platform uses AI and machine learning to model crop performance and generate Smart Alerts delivered as push notifications to farmers’ smartphones. These proactive alerts highlight specific problems in field areas so farmers can intervene, rescue yield, capture learnings, and identify conservation opportunities for sustainable farming. The company plans to use new funds to scale operations and further develop the AGMRI® platform. Intelinair is led by CEO Al Eisaian and maintains offices in Indianapolis and Champaign, Illinois. The company was founded in 2015. IntelinAir is a San Jose-based automated aerial imagery analytics startup that delivers health analytics for crops. The company combines high-resolution aerial imagery with advanced agronomic sciences and proprietary algorithms to generate insights on crop health. IntelinAir closed a seed financing comprising $3.0 million in equity and $500,000 in venture debt. Participating investors included Hyde Park Venture Partners, Western Technology Investments, Harvard Business School Angels of Chicago, Holdsworth & Company, HiveFund, and other angel investors. The financing structure mixes equity and venture debt to expand the company’s capital base for its analytics platform development. No operating metrics or revenue figures were disclosed in the article.